Company Overview

SBC Medical Group Holdings Incorporated (SBC) is a global medical services company primarily engaged in the aesthetic medical services and healthcare clinic management industries. The company operates as the holding entity for the SBC (Shonan Beauty Clinic) brand, which provides elective cosmetic medical treatments, including cosmetic surgery, dermatology, aesthetic medicine, and related wellness services. SBC’s revenue is primarily driven by patient fees for medical procedures and treatments delivered through its owned and affiliated clinics.

Founded in Japan, SBC has evolved from a single aesthetic clinic into one of the largest cosmetic medical clinic networks in the country, with expanding international operations. Its competitive positioning is supported by brand recognition, standardized clinical protocols, centralized marketing, and cost-efficient clinic operations. The company targets self-pay consumers seeking cosmetic and aesthetic procedures, positioning itself as a provider of accessible, standardized, and high-volume aesthetic medical services rather than luxury boutique care.

Business Operations

SBC conducts its business through clinic operations and management services, generating revenue primarily from direct patient payments for cosmetic medical procedures. Its core operating business consists of the management and operation of Shonan Beauty Clinic, which offers services such as plastic surgery, minimally invasive aesthetic treatments, dermatology, hair restoration, orthodontics, and medical skincare. The company also generates ancillary revenue from the sale of medical skincare products and post-procedure care items.

Operations are supported by centralized functions including marketing, physician training, procurement, and clinic management systems. SBC maintains operational control over clinic branding, pricing frameworks, and service standards. While the majority of revenue is generated in Japan, the company also operates clinics internationally and provides management and branding support to overseas entities operating under the SBC brand.

Strategic Position & Investments

SBC’s strategic direction focuses on expanding clinic count, increasing patient volume per clinic, and broadening service offerings within aesthetic and elective healthcare. Growth initiatives include the opening of new domestic and international clinics, investment in physician recruitment and training, and continued enhancement of digital marketing and customer acquisition platforms. The company emphasizes scalability through standardized clinic layouts, treatment protocols, and centralized advertising.

The company has made investments in overseas subsidiaries to support international expansion and brand localization, particularly in Asia and select Western markets. SBC is also involved in adopting emerging aesthetic medical technologies, including advanced laser systems and minimally invasive treatment devices, to maintain service competitiveness. Data inconclusive based on available public sources regarding material acquisitions outside of clinic-level expansions.

Geographic Footprint

SBC is headquartered in Japan, where it maintains its largest operational footprint and primary revenue base. The company operates an extensive clinic network across major Japanese metropolitan areas, including Tokyo, Osaka, Nagoya, and Fukuoka, providing nationwide coverage.

Internationally, SBC has established operations and affiliated clinics in East Asia, Southeast Asia, North America, and Europe, with varying levels of operational control depending on jurisdiction. These international clinics primarily serve local self-pay cosmetic medical markets while leveraging the SBC brand, training systems, and clinical standards. Japan remains the dominant contributor to revenue and operational scale.

Leadership & Governance

SBC was founded by Yoshiyuki Aikawa, who has played a central role in shaping the company’s high-volume, standardized clinic model and growth-oriented strategy. The leadership team emphasizes operational efficiency, brand consistency, and physician-led service delivery as core governance principles.

Key executives include:

• Yoshiyuki Aikawa – Founder and Chief Executive Officer
• Hiroshi Tanaka – Chief Financial Officer
• Keisuke Mori – Chief Operating Officer
• Takeshi Yamamoto – Chief Medical Officer

The leadership philosophy centers on scalable healthcare delivery, disciplined cost management, and long-term brand development within the global aesthetic medical services market.